相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Agents and Approaches for Advanced Renal Cell Carcinoma
Robert Figlin et al.
JOURNAL OF UROLOGY (2012)
Interferon-α Induces G1 Cell-Cycle Arrest in Renal Cell Carcinoma Cells Via Activation of Jak-Stat Signaling
Donghao Shang et al.
CANCER INVESTIGATION (2011)
An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells
YuMing Guo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
The Epidemiology of Renal Cell Carcinoma
Borje Ljungberg et al.
EUROPEAN UROLOGY (2011)
Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells
Jing-Shan Tong et al.
PLOS ONE (2011)
Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3/AKT Signalings
Jian Feng Zhu et al.
PLOS ONE (2011)
STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma
A. Horiguchi et al.
BRITISH JOURNAL OF CANCER (2010)
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
J-F Rossi et al.
BRITISH JOURNAL OF CANCER (2010)
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Michael Hedvat et al.
CANCER CELL (2009)
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Jacqueline Bromberg et al.
CANCER CELL (2009)
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
Julia Bollrath et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
Hong Xin et al.
CANCER RESEARCH (2009)
Enhanced co-expression of β-tubulin III and choline acetyltransferase in neurons from mouse embryonic stem cells promoted by icaritin in an estrogen receptor-independent manner
Zhiqiang Wang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Sandra Rebouissou et al.
NATURE (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Reactive oxygen species involved in prenylflavonoids, icariin and icaritin, initiating cardiac differentiation of mouse embryonic stem cells
Yan-Bo Wo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro
Jian Huang et al.
LIFE SCIENCES (2007)
Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-α resistance
Donghao Shang et al.
CANCER SCIENCE (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Neuroprotective amyloid-induced neuronal cells effects of icaritin against beta neurotoxicity in primary cultured rat via estrogen-depen dent pathway
Z. Wang et al.
NEUROSCIENCE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Interferon-γ-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal anglomyolipoma -: A potential therapeutic target
N El-Hashemite et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs
C Luo et al.
DRUG DISCOVERY TODAY (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
A new modality for immunosuppression: Targeting the JAK/STAT pathway
JJ O'Shea et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
TH Wang et al.
NATURE MEDICINE (2004)
A critical role for stat3 signaling in immune tolerance
FD Cheng et al.
IMMUNITY (2003)
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
G Niu et al.
ONCOGENE (2002)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: A study of incidence and its association with pathological features and clinical outcome
A Horiguchi et al.
JOURNAL OF UROLOGY (2002)
STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P
A Horiguchi et al.
KIDNEY INTERNATIONAL (2002)
The role of STATs in transcriptional control and their impact on cellular function
J Bromberg et al.
ONCOGENE (2000)
Systemic therapy for renal cell carcinoma
RJ Motzer et al.
JOURNAL OF UROLOGY (2000)
分享论文
